BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38237479)

  • 21. Classification of early stage non-small cell lung cancers on computed tomographic images into histological types using radiomic features: interobserver delineation variability analysis.
    Haga A; Takahashi W; Aoki S; Nawa K; Yamashita H; Abe O; Nakagawa K
    Radiol Phys Technol; 2018 Mar; 11(1):27-35. PubMed ID: 29209915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parallel comparison and combining effect of radiomic and emerging genomic data for prognostic stratification of non-small cell lung carcinoma patients.
    Kim KH; Kim J; Park H; Kim H; Lee SH; Sohn I; Lee HY; Park WY
    Thorac Cancer; 2020 Sep; 11(9):2542-2551. PubMed ID: 32700470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing brain metastasis prediction in non-small cell lung cancer: a deep learning-based segmentation and CT radiomics-based ensemble learning model.
    Gong J; Wang T; Wang Z; Chu X; Hu T; Li M; Peng W; Feng F; Tong T; Gu Y
    Cancer Imaging; 2024 Jan; 24(1):1. PubMed ID: 38167564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
    Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
    Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phenotype Decoding.
    Khodabakhshi Z; Amini M; Hajianfar G; Oveisi M; Shiri I; Zaidi H
    Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):713-725. PubMed ID: 37599160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans.
    Khorrami M; Bera K; Thawani R; Rajiah P; Gupta A; Fu P; Linden P; Pennell N; Jacono F; Gilkeson RC; Velcheti V; Madabhushi A
    Eur J Cancer; 2021 May; 148():146-158. PubMed ID: 33743483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method.
    Zhang H; Liao M; Guo Q; Chen J; Wang S; Liu S; Xiao F
    Med Phys; 2023 Apr; 50(4):2049-2060. PubMed ID: 36563341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early survival prediction in non-small cell lung cancer from PET/CT images using an intra-tumor partitioning method.
    Astaraki M; Wang C; Buizza G; Toma-Dasu I; Lazzeroni M; Smedby Ö
    Phys Med; 2019 Apr; 60():58-65. PubMed ID: 31000087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
    Peng J; Zou D; Zhang X; Ma H; Han L; Yao B
    J Transl Med; 2024 Jan; 22(1):87. PubMed ID: 38254087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
    Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
    Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing the radiomics-machine-learning model based on non-contrast enhanced CT for the simplified risk categorization of thymic epithelial tumors: A large cohort retrospective study.
    Feng XL; Wang SZ; Chen HH; Huang YX; Xin YK; Zhang T; Cheng DL; Mao L; Li XL; Liu CX; Hu YC; Wang W; Cui GB; Nan HY
    Lung Cancer; 2022 Apr; 166():150-160. PubMed ID: 35287067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A PET/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study.
    Yu L; Zhang Z; Yi H; Wang J; Li J; Wang X; Bai H; Ge H; Zheng X; Ni J; Qi H; Guan Y; Xu W; Zhu Z; Xing L; Dekker A; Wee L; Traverso A; Ye Z; Yuan Z
    Radiat Oncol; 2024 Jan; 19(1):10. PubMed ID: 38254106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomics for Classification of Lung Cancer Histological Subtypes Based on Nonenhanced Computed Tomography.
    E L; Lu L; Li L; Yang H; Schwartz LH; Zhao B
    Acad Radiol; 2019 Sep; 26(9):1245-1252. PubMed ID: 30502076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
    Blanc-Durand P; Campedel L; Mule S; Jegou S; Luciani A; Pigneur F; Itti E
    Eur Radiol; 2020 Jun; 30(6):3528-3537. PubMed ID: 32055950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of CT radiomic features combined with clinical factors in predicting prognosis in patients with limited-stage small cell lung cancer.
    Wu J; Zhou Y; Xu C; Yang C; Liu B; Zhao L; Song J; Wang W; Yang Y; Liu N
    BMC Cancer; 2024 Feb; 24(1):170. PubMed ID: 38310283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival in Non-Small-Cell Lung Cancer.
    Jha AK; Sherkhane UB; Mthun S; Jaiswar V; Purandare N; Prabhash K; Wee L; Rangarajan V; Dekker A
    J Digit Imaging; 2023 Dec; 36(6):2519-2531. PubMed ID: 37735307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homological radiomics analysis for prognostic prediction in lung cancer patients.
    Ninomiya K; Arimura H
    Phys Med; 2020 Jan; 69():90-100. PubMed ID: 31855844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.